Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 and Its Related Molecules as Potential Biomarkers in Small-Cell Lung Cancer

Table 1

Relationship between the expression level of IGF2BP3 and clinical features.

Characteristic	Low expression of IGF2BP3	High expression of IGF2BP3
	518	519
T stage, (%)			<0.001
T1	178 (17.2%)	111 (10.7%)
T2	260 (25.1%)	323 (31.2%)
T3	56 (5.4%)	64 (6.2%)
T4	21 (2%)	21 (2%)
N stage, (%)			<0.001
N0	357 (35.2%)	311 (30.6%)
N1	87 (8.6%)	139 (13.7%)
N2	56 (5.5%)	58 (5.7%)
N3	1 (0.1%)	6 (0.6%)
M stage, (%)			0.184
M0	378 (47%)	395 (49.1%)
M1	20 (2.5%)	12 (1.5%)
Gender, (%)			<0.001
Female	244 (23.5%)	173 (16.7%)
Male	274 (26.4%)	346 (33.4%)
Race, (%)			0.526
Asian	7 (0.8%)	9 (1.1%)
Black or African American	48 (5.6%)	37 (4.3%)
White	386 (45%)	370 (43.2%)
Age, median (IQR)	67 (60, 73)	67 (59, 73)	0.383